Supriya Lifescience Limited — Investor Relations & Filings
Supriya Lifescience Limited is a research-driven manufacturer of Active Pharmaceutical Ingredients (APIs) with a focus on diverse therapeutic segments. The company specializes in the production of antihistamines, anti-allergics, vitamins, anesthetics, and anti-asthmatics. Its core product portfolio includes Chlorpheniramine Maleate, Ketamine Hydrochloride, and Salbutamol Sulphate, maintaining a significant global market share in these niche categories. Operating with a strong emphasis on backward integration, the firm ensures supply chain reliability and cost efficiency. The manufacturing infrastructure is compliant with international regulatory standards, including approvals from the USFDA, EDQM, and PMDA. Supriya Lifescience serves a broad international clientele across more than 100 countries, catering to both regulated and semi-regulated markets through its advanced R&D capabilities and commitment to quality excellence.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| General Updates | 2026-04-22 | English | |
| Shareholders meeting | 2026-04-11 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-10 | English | |
| Trading Window | 2026-03-25 | English | |
| Change in Director(s) | 2026-03-24 | English | |
| Reply to Clarification- Financial results | 2026-03-13 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42182500 | General Updates | 2026-04-22 | English | ||
| 42195800 | Shareholders meeting | 2026-04-11 | English | ||
| 42206530 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-10 | English | ||
| 42181490 | Trading Window | 2026-03-25 | English | ||
| 42193625 | Change in Director(s) | 2026-03-24 | English | ||
| 42196646 | Reply to Clarification- Financial results | 2026-03-13 | English | ||
| 42168202 | Copy of Newspaper Publication | 2026-03-11 | English | ||
| 42179477 | Shareholders meeting | 2026-03-10 | English | ||
| 42189781 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-02-17 | English | ||
| 42236162 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-02-10 | English | ||
| 42241780 | Copy of Newspaper Publication | 2026-02-10 | English | ||
| 42241946 | Press Release | 2026-02-10 | English | ||
| 42248209 | Investor Presentation | 2026-02-09 | English | ||
| 42248562 | Change in Director(s) | 2026-02-09 | English | ||
| 42248932 | Outcome of Board Meeting | 2026-02-09 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Supriya Lifescience Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/59375/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=59375 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=59375 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=59375 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 59375}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Supriya Lifescience Limited (id: 59375)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.